1. Bio-Tech Sector Update News & Headlines

2. Recent Activity & Numbers

3. In the News EU Court Backs Generics And Deals Blow To AstraZeneca EU Court Backs Generics And Deals Blow To AstraZeneca Eli Lilly and Company: Strattera Prescriptions Double in Three-Month Period Eli Lilly and Company: Strattera Prescriptions Double in Three-Month Period GlaxoSmithKline Takes Further Action to Help the World's Poorest Fight HIV/AIDS GlaxoSmithKline Takes Further Action to Help the World's Poorest Fight HIV/AIDS

4. 3 rd Quarter Profit Announcements Decrease Schering-Plough- -66% AstraZeneca- -13% Eli Lilly expected to announce small loss Increase Wyeth Profits- +28% Pfizer and GlaxoSmithKline also expected to announce increase in profits

5. Dividend Re-Investment Plan Also Known as DRIPs

6. Example Suppose you have 1000 shares of JNJ at $50 dollars per share You annually receive a $3 dollar per share dividend from JNJ which = $3000 The Dividend Yield is 3/50=6% In DRIPs you use the $3000 to buy 60 more shares of stock